Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine palmitoyltransferase long chain base subunit 1 pseudogene 4 (SPTLC1P4)
- Target
- SPTLC1P4
- Molecular classification
- Other (Pseudogene), Not an enzyme, receptor, transporter, or typical druggable target family.
01
Overview
Serine palmitoyltransferase long chain base subunit 1 pseudogene 4 (SPTLC1P4) is one of several genomic sequences resembling the functional SPTLC1 gene, but it harbors features (such as frameshift mutations or premature stop codons) that prevent it from encoding a functional protein[6]. Pseudogenes like SPTLC1P4 are typically byproducts of genome evolution and do not participate in canonical cellular functions; they lack the enzymatic or receptor activity of their parent genes. Although some pseudogenes have regulatory RNA functions, there is no evidence that SPTLC1P4 is transcribed or functionally relevant in human health or disease.
- Other names
- SPTLC1 pseudogene 4SPTLC1P4
02
Mechanism of action
None. As a pseudogene, there is no protein for drug engagement.
03
Biological functions
None (pseudogenes do not usually perform biological functions)There is no evidence that SPTLC1P4 encodes a functional protein or has regulatory RNA function in the literature or curated genetic databases[6][4].
04
Disease associations
None establishedNo association with cancer, neurodegenerative, inflammatory, or other diseases is reported for SPTLC1P4. Disease relevance documented for the functional SPTLC1 gene does not extend to its pseudogenes[1][3][6].
05
Safety considerations
NoneAs a non-functional pseudogene, SPTLC1P4 does not raise safety concerns in therapy or clinical studies.
06
Interacting drugs
None
1 more in the full profile.
07
Biomarkers
NoneSPTLC1P4 is not used as a biomarker for patient selection or efficacy monitoring.
Beyond the preview
Go deeper on Serine palmitoyltransferase long chain base subunit 1 pseudogene 4 (SPTLC1P4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serine palmitoyltransferase long chain base subunit 1 pseudogene 4 (SPTLC1P4).